Omalizumab in chronic spontaneous urticaria treatment: real life experiences
Burhan Engіn +5 more
openalex +1 more source
Vitamin D and Disease Perception Outcomes in a Cluster of Patients with High-Disease-Activity Chronic Spontaneous Urticaria. [PDF]
Lekli E +7 more
europepmc +1 more source
Treatments and Targets to Achieve Disease Control in Chronic Spontaneous Urticaria: Current and Emerging Therapeutic Options. [PDF]
Østergaard CES, Thomsen SF, Zhang DG.
europepmc +1 more source
Cytokine imbalance and immune network endotypes underlying heterogeneous response to omalizumab in chronic spontaneous urticaria [PDF]
Young-Min Ye +5 more
openalex +1 more source
Efficacy and safety of acupuncture for chronic spontaneous urticaria: a systematic review and meta-analysis. [PDF]
Tong Y, Jin R, Yu Y, Xia S, Wu Z, Su X.
europepmc +1 more source
Remibrutinib Treatment Has No Impact on Blood Counts in Patients With Chronic Spontaneous Urticaria: Results From Phase 2b 52-week Extension Study Results [PDF]
Alexander Greiner +8 more
openalex +1 more source
Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria. [PDF]
Mosnaim G +4 more
europepmc +1 more source
The burden of chronic spontaneous urticaria in Europe: Call for action. [PDF]
Kocatürk E, Thomsen SF.
europepmc +1 more source
Expanding treatment options in chronic spontaneous urticaria: the emerging role of dupilumab. [PDF]
Fathima Haseena H +2 more
europepmc +1 more source
Systemic lupus erythematosus comorbid with chronic spontaneous urticaria: a multicentre retrospective study. [PDF]
Zeng X +12 more
europepmc +1 more source

